| Literature DB >> 16231040 |
J Harlan1, Y Chen, E Gubbins, R Mueller, J-M Roch, K Walter, M Lake, T Olsen, P Metzger, S Dorwin, U Ladror, D A Egan, J Severin, R W Johnson, T F Holzman, K Voelp, C Davenport, A Beck, J Potter, M Gopalakrishnan, A Hahn, B B Spear, D N Halbert, J P Sullivan, V Abkevich, C D Neff, M H Skolnick, D Shattuck, D A Katz.
Abstract
APAF1, encoding the protein apoptosis protease activating factor 1 (Apaf-1), has recently been established as a chromosome 12 gene conferring predisposition to major depression in humans. The molecular phenotypes of Apaf-1 variants were determined by in vitro reconstruction of the apoptosome complex in which Apaf-1 activates caspase 9 and thus initiates a cascade of proteolytic events leading to apoptotic destruction of the cell. Cellular phenotypes were measured using a yeast heterologous expression assay in which human Apaf-1 and other proteins necessary to constitute a functional apoptotic pathway were overexpressed. Apaf-1 variants encoded by APAF1 alleles that segregate with major depression in families linked to chromosome 12 shared a common gain-of-function phenotype in both assay systems. In contrast, other Apaf-1 variants showed neutral or loss-of-function phenotypes. The depression-associated alleles thus have a common phenotype that is distinct from that of non-associated variants. This result suggests an etiologic role for enhanced apoptosis in major depression.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16231040 DOI: 10.1038/sj.mp.4001755
Source DB: PubMed Journal: Mol Psychiatry ISSN: 1359-4184 Impact factor: 15.992